This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 A Jemal , R Siegel , J Xu , et al. (2010) Cancer statistics, 2010. CA Cancer J Clin 60, 277–300.
3 A Jemal , T Murray , E Ward , et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55, 10–30.
4 RD Etzioni , N Howlader , PA Shaw , et al. (2005) Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. J Urol 174, 877–881.
5 M Saraiya , BJ Kottiri , S Leadbetter , et al. (2005) Total and percent free prostate-specific antigen levels among U.S. men, 2001–2002. Cancer Epidemiol Biomarkers Prev 14, 2178–2182.
6 WJ Catalona , AW Partin , KM Slawin , et al. (2000) Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial. Urology 55, 372–376.
7 LP Wallner , H Morgenstern , ME McGree , et al. (2011) The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study. Urology 77, 137–141.
8 GA Sonn , W Aronson & MS Litwin (2005) Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 8, 304–310.
10 RL Grubb 3rd, A Black , G Izmirlian , et al. (2009) Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 18, 748–751.
11 EA Singer , GS Palapattu & E van Wijngaarden (2008) Prostate-specific antigen levels in relation to consumption of nonsteroidal anti-inflammatory drugs and acetaminophen: results from the 2001–2002 National Health and Nutrition Examination Survey. Cancer 113, 2053–2057.
12 LS Krane , SA Kaul , HJ Stricker , et al. (2010) Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J Urol 183, 118–124.
13 A Jemal , F Bray , MM Center , et al. (2011) Global cancer statistics. CA Cancer J Clin 61, 69–90.
14 P Astorg (2004) Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 15, 367–386.
15 IM Berquin , Y Min , R Wu , et al. (2007) Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest 117, 1866–1875.
16 KL Weaver , P Ivester , M Seeds , et al. (2009) Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem 284, 15400–15407.
17 AP Simopoulos (2003) Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. World Rev Nutr Diet 92, 1–22.
19 DP Rose & JM Connolly (1999) Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 83, 217–244.
20 JM Connolly , M Coleman & DP Rose (1997) Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr Cancer 29, 114–119.
21 JA Akinsete , G Ion , TR Witte , et al. (2012) Consumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice. Carcinogenesis 33, 140–148.
22 UP Kelavkar , J Hutzley , R Dhir , et al. (2006) Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 8, 112–124.
23 N Kobayashi , RJ Barnard , SM Henning , et al. (2006) Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 12, 4662–4670.
24 GF Watts , DA Playford , KD Croft , et al. (2002) Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia 45, 420–426.
25 W Chai , RV Cooney , AA Franke , et al. (2011) Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 20, 708–710.
26 KM Hoenjet , PC Dagnelie , KP Delaere , et al. (2005) Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study. Eur Urol 47, 433–439.
27 JI Harris , JR Hibbeln , RH Mackey , et al. (2004) Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukot Essent Fatty Acids 71, 263–269.
29 S Loeb , HB Carter , EM Schaeffer , et al. (2009) Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging. J Urol 182, 2646–2651.
31 JH Fowke , LB Signorello , SS Chang , et al. (2006) Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 107, 2361–2367.
32 MR Safarinejad , N Shafiei & S Safarinejad (2010) Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case–control study. Prostate 70, 1645–1657.
34 LN Kolonel (2001) Fat, meat, and prostate cancer. Epidemiol Rev 23, 72–81.
37 P Terry , P Lichtenstein , M Feychting , et al. (2001) Fatty fish consumption and risk of prostate cancer. Lancet 357, 1764–1766.
38 NE Allen , C Sauvaget , AW Roddam , et al. (2004) A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control 15, 911–920.
39 L Le Marchand , LN Kolonel , LR Wilkens , et al. (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5, 276–282.
40 PK Mills , WL Beeson , RL Phillips , et al. (1989) Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64, 598–604.
41 SY Park , SP Murphy , LR Wilkens , et al. (2007) Fat and meat intake and prostate cancer risk: the multiethnic cohort study. Int J Cancer 121, 1339–1345.
42 W Friedrichs , SB Ruparel , RA Marciniak , et al. (2011) Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression. Nutr Cancer 63, 771–777.
43 EJ Giltay , JM Geleijnse , AC Heijboer , et al. (2012) No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial. Int J Androl 35, 680–687.
44 AC Reese , V Fradet & JS Witte (2009) Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer. J Nutrigenet Nutrigenomics 2, 149–158.
45 V Fradet , I Cheng , G Casey , et al. (2009) Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 15, 2559–2566.
46 FL Crane (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20, 591–598.
50 K Folkers , A Osterborg , M Nylander , et al. (1997) Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem Biophys Res Commun 234, 296–299.